Rainbow Children's Medicare Limited

NSEI:RAINBOW 株式レポート

時価総額:₹142.2b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Rainbow Children's Medicare 将来の成長

Future 基準チェック /46

Rainbow Children's Medicare利益と収益がそれぞれ年間17%と17.3%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に19.4% 18.1%なると予測されています。

主要情報

21.4%

収益成長率

21.8%

EPS成長率

Healthcare 収益成長26.4%
収益成長率17.8%
将来の株主資本利益率19.3%
アナリストカバレッジ

Good

最終更新日19 Sep 2024

今後の成長に関する最新情報

Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Aug 16
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

May 23
Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

Recent updates

Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Sep 24
Is Rainbow Children's Medicare (NSE:RAINBOW) A Risky Investment?

Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Sep 06
Some Confidence Is Lacking In Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E

Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Aug 16
Earnings Miss: Rainbow Children's Medicare Limited Missed EPS By 5.1% And Analysts Are Revising Their Forecasts

Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Jun 26
Rainbow Children's Medicare (NSE:RAINBOW) Is Experiencing Growth In Returns On Capital

Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

May 27
Rainbow Children's Medicare (NSE:RAINBOW) Strong Profits May Be Masking Some Underlying Issues

Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

May 23
Analysts Have Made A Financial Statement On Rainbow Children's Medicare Limited's (NSE:RAINBOW) Full-Year Report

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

May 07
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Mar 20
Some Shareholders Feeling Restless Over Rainbow Children's Medicare Limited's (NSE:RAINBOW) P/E Ratio

Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Feb 13
Returns At Rainbow Children's Medicare (NSE:RAINBOW) Are On The Way Up

Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Jan 18
Is Now The Time To Put Rainbow Children's Medicare (NSE:RAINBOW) On Your Watchlist?

Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Nov 07
Impressive Earnings May Not Tell The Whole Story For Rainbow Children's Medicare (NSE:RAINBOW)

Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

Oct 18
Here's Why Rainbow Children's Medicare (NSE:RAINBOW) Has Caught The Eye Of Investors

A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

Aug 29
A Look At The Fair Value Of Rainbow Children's Medicare Limited (NSE:RAINBOW)

With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Jul 08
With EPS Growth And More, Rainbow Children's Medicare (NSE:RAINBOW) Makes An Interesting Case

Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 18
Earnings Beat: Rainbow Children's Medicare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Feb 11
Getting In Cheap On Rainbow Children's Medicare Limited (NSE:RAINBOW) Is Unlikely

Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

Sep 20
Are Investors Undervaluing Rainbow Children's Medicare Limited (NSE:RAINBOW) By 24%?

業績と収益の成長予測

NSEI:RAINBOW - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202721,9823,8332,159N/A5
3/31/202618,5983,1492,637N/A9
3/31/202515,5322,4031,861N/A9
6/30/202413,4002,155N/AN/AN/A
3/31/202412,9692,170-3223,214N/A
12/31/202312,7282,196N/AN/AN/A
9/30/202312,4322,154563,299N/A
6/30/202312,2362,136N/AN/AN/A
3/31/202311,7362,1081,8753,288N/A
12/31/202210,6911,690N/AN/AN/A
9/30/202210,1141,5601,2942,248N/A
6/30/20229,6461,405N/AN/AN/A
3/31/20229,7381,3781,6152,237N/A
12/31/20219,2521,2691,8562,454N/A
9/30/20218,5289721,5982,311N/A
6/30/20217,415642N/AN/AN/A
3/31/20216,5004006661,427N/A
3/31/20207,1945499591,704N/A
3/31/20195,4284433981,272N/A

アナリストによる今後の成長予測

収入対貯蓄率: RAINBOWの予測収益成長率 (年間17% ) は 貯蓄率 ( 6.7% ) を上回っています。

収益対市場: RAINBOWの収益 ( 18.6% ) はIndian市場 ( 16.9% ) よりも速いペースで成長すると予測されています。

高成長収益: RAINBOWの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: RAINBOWの収益 ( 17.3% ) Indian市場 ( 9.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: RAINBOWの収益 ( 17.3% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: RAINBOWの 自己資本利益率 は、3年後には低くなると予測されています ( 19.4 %)。


成長企業の発掘